Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Infiltrated and nodular pinna in lepromatous leprosy.

Vangala N, Madke B, Kashikar Y, et al. BMJ case reports. 2024;
Publication

Genetic diversity of Mycobacterium leprae: Need to move towards genome-wide approaches.

Dwivedi P, Sharma M, Ansari A, et al. The Indian journal of medical research. 2024; 159 (2) : 121-129.
Download PDF
Publication

Australia Antigen in Lepromatous Leprosy Patients

Sinha S. K, Banerjee P. P, Bangal M. L , et al. Indian Journal of Dermatology. 1995; 40 (1) : 36-37.
Download PDF
Publication

Lepromatous Leprosy with Scrotal Nodules

Feroz K., Varghese M., Sakumar D, et al. Indian Journal of Dermatology. 2003; 48 (2) : 96-98.
Download PDF
Publication

A Cross-Sectional Study to Evaluate the Role of the Nuclear Factor Kappa B (Nf-κB) Pathway in Regulating the Cytokine Cascade and as a Potential Therapeutic Target in Leprosy

Reja H, Hena A, Abishek De, et al. Indian Journal of Dermatology. 2024;
Download PDF
Publication

Morphological Index as a Sensitive Marker of Drug Resistance in Leprosy: A Case Series

Chhabra N, Kumar TS, Singh I, et al. Medknow. Indian Journal of Dermatology. 2024;
Download PDF
Publication

Onychoscopy and nailfold capillaroscopy in leprosy: A case–control study

Chanana C, Palanisamy M, Goyal A, et al. Scientific Scholar. Cosmoderma. 2024;
Download PDF
Publication

Dermatoscopic evaluation of leprosy: A multi-centre cross-sectional study

Ankad BS, Sharma A, Vinay K, et al. Scientific Scholar. Indian Journal of Dermatology, Venereology and Leprology. 2024;
Download PDF
Publication

An Investigation on Leprosy Treatment Patterns, including Disease Prevalence, Adverse Event Monitoring, and Medication Adherence Assessment.

Turki A, Mallick S, Begum H. A, et al. Journal of Advanced Zoology. 2024;
Publication

Steroid Premedication Might Protect From Postoperative Erythema Nodosum Leprosum in Leprosy: A Case Report

Hembrom SB, Ahmed G, Karim HMR, et al. Springer Science and Business Media LLC. Cureus. 2024;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 20
  • Next page ››
Subscribe to India

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD